- Home
- CLLS vs REFI Comparison
CLLS vs REFI Comparison
Compare CLLS & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- REFI
- Stock Information
- Founded
- CLLS 1999
- REFI 2021
- Country
- CLLS France
- REFI United States
- Employees
- CLLS N/A
- REFI N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- REFI Real Estate Investment Trusts
- Sector
- CLLS Health Care
- REFI Real Estate
- Exchange
- CLLS Nasdaq
- REFI Nasdaq
- Market Cap
- CLLS 299.0M
- REFI 255.6M
- IPO Year
- CLLS 2007
- REFI 2021
- Fundamental
- Price
- CLLS $3.85
- REFI $12.67
- Analyst Decision
- CLLS Buy
- REFI Strong Buy
- Analyst Count
- CLLS 1
- REFI 3
- Target Price
- CLLS $8.00
- REFI $20.00
- AVG Volume (30 Days)
- CLLS 73.5K
- REFI 92.2K
- Earning Date
- CLLS 11-07-2025
- REFI 11-04-2025
- Dividend Yield
- CLLS N/A
- REFI 16.23%
- EPS Growth
- CLLS N/A
- REFI N/A
- EPS
- CLLS N/A
- REFI 1.69
- Revenue
- CLLS $82,551,000.00
- REFI $54,287,847.00
- Revenue This Year
- CLLS N/A
- REFI $11.43
- Revenue Next Year
- CLLS $58.00
- REFI $4.75
- P/E Ratio
- CLLS N/A
- REFI $7.49
- Revenue Growth
- CLLS 129.04
- REFI N/A
- 52 Week Low
- CLLS $1.10
- REFI $12.00
- 52 Week High
- CLLS $5.48
- REFI $16.29
- Technical
- Relative Strength Index (RSI)
- CLLS 58.54
- REFI 43.45
- Support Level
- CLLS $3.49
- REFI $12.51
- Resistance Level
- CLLS $3.86
- REFI $12.97
- Average True Range (ATR)
- CLLS 0.22
- REFI 0.23
- MACD
- CLLS 0.03
- REFI -0.00
- Stochastic Oscillator
- CLLS 89.76
- REFI 27.54
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.